← SynDRA
REMIMAZOLAM
SynDRA canonical compound SYN0039672 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | GABBR1 |
|---|
| Mechanism of action | benzodiazepine receptor agonist |
|---|
All known targets
- GABRG3
- GABBR1
- GABRA1
- GABRA2
- GABRA3
- GABRA5
- GABRG1
- GABRG2
- Gabra1
- Gabra2
- Gabra3
- Gabra5
Mechanisms of action (all sources)
- benzodiazepine receptor agonist
- GABRG3 AGONIST
- GABRA1 MODULATOR
- GABRA2 MODULATOR
- GABRA3 MODULATOR
- GABRA5 MODULATOR
- GABRG1 MODULATOR
- GABRG2 MODULATOR
- GABRG3 MODULATOR
ATC classes
- N05C · HYPNOTICS AND SEDATIVES
Cross-references
Synonyms
- remimazolam besylate
- byfavo
- CNS 7056
- CNS 7056B
- ONO-2745BS
- ONO-2745
- anerem
- aptimyda
- CNS-7056
- CNS-7054
- CNS-7056B
- CNS-7056X
- GW-351564X
- GW-418259X
- GW-457837A
- GW-502056X
- Short-acting sedatives, Therasci
- GABA A agonist (anesthesia, sedation) CeNeS/Ono
- Sedatives (short acting), CeNeS/Ono
- Sedatives (short acting), PAION/Ono
- Sedatives (short-acting), TheraSci
- Short-acting sedatives, Therasci/GSK
- Sedatives (short-acting), TheraSci/GSK
- 4H-IMIDAZOL(1,2-A)(1,4)BENZODIAZEPINE-4-PROPIONIC ACID, (S)-
- ONO 2745
- 7V4A8U16MB
- ONO2745
- CNS7056
- remimazolamum
- RefChem:57866
- N05CD14
- Byfavo (TN)
- Remimazolam [INN]
- UNII-7V4A8U16MB
- REMIMAZOLAM [MI]
- Remimazolam (USAN/INN)
- Remimazolam [USAN:INN]
- REMIMAZOLAM [USAN]
Reported adverse events
- Bradycardia
- Headache
- Hypotension
- Hypoxia
- Nausea
- Respiratory rate decreased
- Diastolic hypotension
- Blood pressure diastolic increased
- Blood pressure increased
- Blood pressure systolic increased
- Diastolic hypertension
- Hypertension
Look up REMIMAZOLAM in the interactive SynDRA portal →